NASDAQ: ITRM
Iterum Therapeutics PLC Stock Ownership - Who owns Iterum Therapeutics?

Insider buying vs selling

Have Iterum Therapeutics PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael W. DunneDirector2025-08-0815,000$0.72
$10.86kBuy

1 of 1

ITRM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ITRM insiders and whales buy or sell their stock.

ITRM Shareholders

What type of owners hold Iterum Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP26.09%11,651,597$7.97MInsider
Brenton Karl Ahrens3.88%1,733,580$1.19MInsider
Canaan X LP3.88%1,733,170$1.19MInsider
James Healy3.88%1,732,668$1.19MInsider
Patrick J. Heron3.46%1,547,322$1.06MInsider
Vijay K. Lathi3.26%1,456,303$996.11kInsider
Sofinnova Venture Partners IX LP2.75%1,226,514$838.94kInsider
Shahzad Malik1.94%868,161$593.82kInsider
Renaissance Technologies LLC1.06%471,900$322.78kInstitution
Squarepoint Ops LLC1.02%456,861$312.49kInstitution

1 of 3

ITRM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ITRM5.30%51.07%Net BuyingNet Buying
CLGN16.40%0.00%
CASI2.75%97.25%
PPBT0.01%0.00%
RENB8.38%67.38%

Iterum Therapeutics Stock Ownership FAQ

Who owns Iterum Therapeutics?

Iterum Therapeutics (NASDAQ: ITRM) is owned by 5.30% institutional shareholders, 51.07% Iterum Therapeutics insiders, and 43.63% retail investors. Ra Capital Management LP is the largest individual Iterum Therapeutics shareholder, owning 11.65M shares representing 26.09% of the company. Ra Capital Management LP's Iterum Therapeutics shares are currently valued at $7.91M.

If you're new to stock investing, here's how to buy Iterum Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.